Investing4d
Illumina’s SWOT analysis: next-gen sequencing leader faces headwinds
Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...
Investing4d
Illumina’s SWOT analysis: next-gen sequencing leader faces headwinds
Illumina Inc. (NASDAQ:ILMN), a leading provider of next-generation sequencing (NGS) technology with annual revenue of $4.37 billion, finds itself at a critical juncture as it navigates a shifting ...
PharmiWeb5d
Global Tumor Profiling Market Share Analysis Poised to Reach USD 11.9 Billion by 2025, Driven by Advancements in Precision Oncology | FMI
The global tumor profiling market share analysis is on a strong growth trajectory, projected to reach USD 11.9 billion by 2025, with a CAGR of 8.3% from 2025 to 2035. This surge is fueled by the ...
Breast Cancer Diagnostics Market Set For 6.9% CAGR Growth, Projected To Hit USD 12.45 Billion By 2035
Rise in prevalence of cancer and the necessary attention in early diagnosis and treatment to boost market demand, States Fact.MRRockville, MD, ...
Illumina to cut $100M in costs to cope with China ban
The San Diego company also lowered its financial guidance for 2025 in response to China’s import restrictions.
Illumina lowers outlook due to China sales ban, to cut $100 million in costs
Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban ...
Game Rant6d
More Details on Next-Gen Xbox and New Handheld Revealed
Next-gen Xbox will reportedly be more PC-like, with a "TV-friendly shell" and Windows-based OS. Xbox handheld is supposedly planned for a 2025 release and made in partnership with another company.